Infectious Diseases And Therapy

Infectious Diseases And Therapy

传染病与治疗

  • 2区 中科院分区
  • Q1 JCR分区

期刊简介

《Infectious Diseases And Therapy》是由Springer Healthcare出版社于2012年创办的英文国际期刊(ISSN: 2193-8229,E-ISSN: 2193-6382),该期刊长期致力于传染病学领域的创新研究,主要研究方向为Medicine-Microbiology (medical)。作为SCI、SCIE收录期刊(JCR分区 Q1,中科院 2区),本刊采用OA开放获取模式(OA占比1%),以发表传染病学领域等方向的原创性研究为核心(研究类文章占比81.50%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在173篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Infectious Diseases And Therapy审稿周期约为6 Weeks。该刊近年未被列入国际预警名单,年发文量约173篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 173 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
2区
INFECTIOUS DISEASES 传染病学
2区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
2区
INFECTIOUS DISEASES 传染病学
2区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
INFECTIOUS DISEASES 传染病学
3区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
INFECTIOUS DISEASES 传染病学
4区

期刊分区表(2021年12月基础版)

Top期刊 综述期刊 大类学科 小类学科
医学
2区
INFECTIOUS DISEASES 传染病学
2区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:INFECTIOUS DISEASES SCIE Q1 16 / 141

89

学科:INFECTIOUS DISEASES SCIE Q1 15 / 141

89.72

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:INFECTIOUS DISEASES SCIE Q1 20 / 132

85.2

学科:INFECTIOUS DISEASES SCIE Q1 32 / 132

76.14

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:9.3 SJR:1.66 SNIP:1.724
学科类别 分区 排名 百分位
大类:Medicine 小类:Infectious Diseases Q1 33 / 361

90%

大类:Medicine 小类:Microbiology (medical) Q1 18 / 147

88%

期刊发文

  • Antibiotic Pharmacokinetics and Prostate Penetration in Bacterial Prostatitis: A Systematic Revie

    Author: Ge, Rui; Nian, Xinwen; Liu, Benjuan; Yang, Yunyun; Wang, Zhuo

    Journal: INFECTIOUS DISEASES AND THERAPY. 2026; Vol. 15, Issue 5, pp. 1203-1248. DOI: 10.1007/s40121-026-01341-4

  • Post-marketing Safety Surveillance of 23-Valent Pneumococcal Polysaccharide Vaccine Administered Alone and Concomitantly with Influenza Vaccine in Individuals Aged 2 Years and Older in Chin

    Author: Shi, Yun-feng; Ju, Lin-hang; Wang, Kang-ning; Pan, Yu; Zou, Yu-ying; Lu, Xi; Tuo, Ling; Zou, Wen-tao; Wei, Ming-wei; Zhao, Yan-wei; Pan, Hong-xing

    Journal: INFECTIOUS DISEASES AND THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s40121-026-01309-4

  • Reimagining Phage Therapy for MDR Pathogens: From Biobanks to Health System Integration-A Revie

    Author: Ayele, Abay A.; Liu, Wenfeng; Xiao, Minfeng; Kalayu, Alem A.; Abegaz, Woldaregay E.; Negash, Abel A

    Journal: INFECTIOUS DISEASES AND THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s40121-026-01320-9

  • The Impact and Effectiveness of a Two-Dose Varicella Immunization Program Among School Children: Evidence from Quasi-experimental Analyse

    Author: Gu, Huiqiao; Xie, Xu; Lv, Qiuying; Cui, Yuantian; Lu, Ziyan; Akhmetova, Zaure; Shulgau, Zarina; Huang, Fang; Jiang, Yawen

    Journal: INFECTIOUS DISEASES AND THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s40121-026-01331-6

  • Rising Burden of Herpes Zoster among General Adults and Increased-Risk Groups in Eastern China, 2015-2021: A Population-Based Cohort Stud

    Author: Li, Zhenwei; Gu, Shenjia; Li, Jiajun; Zhang, Guomin; Wu, Zheng; Lin, Hongbo; Chen, Kan; Xu, Zhexin; Fu, Chuanxi

    Journal: INFECTIOUS DISEASES AND THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s40121-026-01308-5

  • Early Antibiotic Therapy in Sepsis Without Shock: A Multimethod Study of Heterogeneous Treatment Effects in ICU Patient

    Author: Zhang, Peng; Zuo, Tongkun; Zhu, Xingxing; Wei, Jilou; Wang, Min; Zhang, Xiangcheng; Huang, Ying

    Journal: INFECTIOUS DISEASES AND THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s40121-026-01316-5

  • How Status Quo Bias Shapes Willingness, Uptake, and Adherence to PrEP Among Chinese MSM: A Behavioral Economics Perspectiv

    Author: Zhao, Min; Zhao, Xiang; Zhang, Ye; Yin, Zhuoheng; Ji, Fanpu; Ong, Jason J.; Tang, Weiming; Zhang, Lei

    Journal: INFECTIOUS DISEASES AND THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s40121-025-01296-y

  • Efficacy, Safety, and Cost-Effectiveness Analysis of Ceftazidime-Avibactam versus Polymyxin B in the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections: A Target Trial Emulatio

    Author: Hu, Na; Xiao, Fengjiao; Chen, Yechao; Gu, Qiaoling; Liang, Pei; Xu, Yin; Liu, Jinchun; Liu, Yunxing; Li, Yi-chen; Xu, Yinqiu; Liu, Mengyin; Chen, Dayu; Zhang, Haixia

    Journal: INFECTIOUS DISEASES AND THERAPY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s40121-025-01164-9